secwatch.observer — SEC 8-K summary
======================================

Issuer:     HARVARD BIOSCIENCE INC (HBIO)
CIK:        0001123494
Form:       8-K
Filed at:   2023-03-09T23:59:59+00:00
Accession:  0001171843-23-001518
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HBIO Q4 revenue $28.4M (-14% YoY), GAAP net loss $1.7M; guides low-single-digit growth in FY23
--------------------------------------------------------------------------------

- Revenues $28.4M, down 14% YoY; negative currency impact of $1.0M.
- GAAP operating loss $0.5M vs income $1.7M; GAAP diluted EPS -$0.04 vs $0.02.
- Adjusted EPS $0.04 vs $0.08; adjusted EBITDA $3.7M vs $5.7M.
- FY23 guidance: low-to-mid single-digit revenue growth, improving gross margin, adjusted EBITDA expansion.
- Plans to reduce leverage ratio to ~2x by year end with improved margins and working capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1123494/000117184323001518/0001171843-23-001518-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1123494/000117184323001518/f8k_030923.htm
  HTML page:      https://secwatch.observer/filing/0001171843-23-001518

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer